The following satellite symposia will be held tomorrow evening from 6:30 to 9 p.m.
UNITED THERAPEUTICS and LUNG RX
Symposium Title: “The PAH Spectrum: Creating the Right Fit with Individualized Treatment Regimens”
Location: New Orleans Riverside; Grand Ballroom A-B
SPEAKERS: Mardi Gomberg-Maitland, MD, MSc (Chair); Murali Chakinala, MD; Ronald J. Oudiz, MD; Erika Berman Rosenzweig, MD
SYMPOSIUM DESCRIPTION
At the conclusion of this session, the participant will be able to:
- Discuss the use of modern diagnostics, baseline biomarkers and clinical assessments to improve diagnosis, monitoring and treatment of patients with PAH;
- Identify patients as candidates for oral, inhaled, or infused therapy and discuss key treatment decisions in early, mid, and late-stage PAH;
- Determine improvements in long-term outcomes by adherence to clinical benchmarks and appropriate PAH therapy escalation; and
- Discuss the future of PAH research and emerging treatment modalities.
Pulmonary arterial hypertension (PAH) is a rare disease of the pulmonary vasculature with a poor prognosis and no known cure. In the last decade, many therapeutic and diagnostic advances have been made in the identification and treatment of PAH. This symposium will focus on the utilization of modern diagnostics in combination with a goal-oriented therapy approach to provide improved treatment to patients with PAH. Expert physicians will present three unique case studies across the full PAH disease spectrum, highlighting critical decision points in the diagnosis and treatment of the disease.
ACTELION PHARMACEUTICALS US, INC.
Symposium Title: “Critical Issues in Pulmonary Arterial Hypertension: An Interactive Fellows Program”
Location: New Orleans Marriott: Mardi Gras D-H
Please note: Attendance for this program is by invitation only.
SPEAKERS: Richard Channick, MD; Paul Forfia, MD; and Sean Studer, MD, MSc, FCCP with a special keynote presentation.
SYMPOSIUM DESCRIPTION
This non-CME, interactive fellows program is designed to provide cutting-edge information and education on important topics related to the recognition, diagnosis and evaluation of the PAH patient.